KIORA PHARMACEUTICALS INC Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Kiora Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • Kiora Pharmaceuticals Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$3.6M, a 39.1% increase year-over-year.
  • Kiora Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was $4.96M.
  • Kiora Pharmaceuticals Inc annual Operating Income (Loss) for 2023 was -$12.6M, a 2.25% decline from 2022.
  • Kiora Pharmaceuticals Inc annual Operating Income (Loss) for 2022 was -$12.3M, a 13.5% increase from 2021.
  • Kiora Pharmaceuticals Inc annual Operating Income (Loss) for 2021 was -$14.2M, a 107% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$12.6M -$277K -2.25% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-25
2022 -$12.3M +$1.93M +13.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
2021 -$14.2M -$7.37M -107% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 -$6.87M Jan 1, 2020 Dec 31, 2020 10-K/A 2022-07-07
2018 -$10.8M Jan 1, 2018 Dec 31, 2018 10-K 2019-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.